|
SRI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.229700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.208000E-02 |
| Normal-vs-Stage2 |
1.300780E-01 |
| Normal-vs-Stage3 |
2.348000E-02 |
| Normal-vs-Stage4 |
7.88980000000494E-05 |
| Stage1-vs-Stage2 |
3.647200E-01 |
| Stage1-vs-Stage3 |
3.224800E-01 |
| Stage1-vs-Stage4 |
3.839600E-03 |
| Stage2-vs-Stage3 |
5.951800E-01 |
| Stage2-vs-Stage4 |
5.664000E-01 |
| Stage3-vs-Stage4 |
8.752300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.960790E-03 |
| Normal-vs-AfricanAmerican |
1.743800E-02 |
| Normal-vs-Asian |
2.727800E-01 |
| Caucasian-vs-AfricanAmerican |
5.902800E-01 |
| Caucasian-vs-Asian |
6.028600E-01 |
| AfricanAmerican-vs-Asian |
7.088800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.891900E-02 |
| Normal-vs-Female |
2.39429999999707E-05 |
| Male-vs-Female |
1.878230E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.602200E-02 |
| Normal-vs-Extreme_Weight |
3.083800E-02 |
| Normal-vs-Obese |
5.315900E-03 |
| Normal-vs-Extreme_Obese |
8.973600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.989000E-01 |
| Normal_Weight-vs-Obese |
3.780800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.236650E-01 |
| Extreme_Weight-vs-Obese |
1.720760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.005200E-01 |
| Obese-vs-Extreme_Obese |
3.668000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.19060000000205E-05 |
| Normal-vs-Age(41-60Yrs) |
2.056500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.102000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.003000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.804000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.495900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.448420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.036200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.870200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.562600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.757380E-04 |
| Normal-VS-Type2 PRCC |
2.903400E-01 |
| Normal-VS-KIRP CIMP |
1.179870E-04 |
| Normal-VS-Unclassified PRCC |
4.581900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.281800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.140630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.683200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.376000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.695600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.688200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.815400E-01 |
| Normal-vs-N1 |
1.018940E-03 |
| Normal-vs-N2 |
8.255300E-03 |
| N0-vs-N1 |
6.624200E-03 |
| N0-vs-N2 |
5.215500E-02 |
| N1-vs-N2 |
6.419200E-01 |
|
|
